Skip to Main Content

Paper Details

The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies.
Proc Natl Acad Sci U S A
106
2022
Author NameAffiliation
Hans-Heinrich HoffmannRockefeller University
James R HeathInstitute for Systems Biology
Giorgio CasariVita-Salute San Raffaele University, and Clinical Genomics, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Ospedale San Raffaele
Luis F ReyesUniversidad de La Sabana
Luis F ReyesClinica Universidad de La Sabana
Christian ErikstrupAarhus University Hospital
Jacques FellayEcole Polytechnique Federale de Lausanne
Jacques FellayLausanne University Hospital and University of Lausanne
Jacques Fellay
Kaya BilguvarYale Center for Genome Analysis, Yale School of Medicine
Kaya BilguvarYale University School of Medicine
Kaya BilguvarYale University School of Medicine
Kaya BilguvarAcibadem University School of Medicine
Richard P LiftonInstitute for Biomedical Research, Spanish National Research Council
Richard P LiftonYale University School of Medicine
Richard P LiftonYale Center for Genome Analysis, Yale School of Medicine
Richard P LiftonInstitute for Biomedical Research, Spanish National Research Council
Richard P LiftonYale Center for Genome Analysis, Yale School of Medicine
Richard P LiftonYale University School of Medicine
Shrikant ManeYale University School of Medicine
Peter K GregersenFeinstein Institutes for Medical Research
Charles M RiceRockefeller University
  • 1 - 22

Datasets